نتایج جستجو برای: indolent

تعداد نتایج: 5476  

2017
Michael A Fridrik

s concerning indolent and aggressive lymphoma and multiple myeloma with clinical relevance from the ASCO 2017 meeting are discussed.

Journal: :Mycoses 1994
G P Prokopowicz S F Bradley C A Kauffman

This paper describes a 71-year-old man with myelodysplasia who required multiple transfusions and subsequent deferoxamine chelation therapy and who then developed indolent cutaneous and probable pulmonary infection with Rhizopus species. The patient did not have rapidly progressive infection as has been described in almost all previously reported deferoxamine-treated patients with zygomycosis. ...

Journal: :Oncology 2007
Julia Schaefer-Cutillo Jonathan W Friedberg Richard I Fisher

Tositumomab/iodine-131 tositumomab (Bexxar) and ibritumomab tiuxetan (Zevalin) are radioimmunoconjugates targeting the CD20 antigen. Both agents are approved in the United States for use in relapsed or refractory, indolent or transformed, B-cell lymphoma. These agents are well tolerated and have the highest levels of single-agent activity observed in these histologies. This review will summariz...

Journal: :Journal of cutaneous pathology 2014
Mina S Ally Alistair Robson

Cutaneous T-cell lymphomas (CTCL) account for almost 65-92% of all cutaneous lymphomas, many of which usually present with multiple lesions. However, a number of well-recognized and rare types of CTCL, including mycosis fungoides, can present in isolated fashion. These solitary lesions often run a relatively indolent clinical course but often pose diagnostic difficulties. We review histopatholo...

Journal: :Tumori 2009
Pierfrancesco Franco Andrea Riccardo Filippi Irene Ricca Carlo Raucci Umberto Ricardi

Ocular adnexal lymphoma is the most frequent malignancy occurring in the eye region. With regard to the histology of these lesions, 2% to 7% of non-Hodgkin's lymphomas located in the periocular region are mantle cell lymphomas. A few cases of mantle cell lymphoma characterized by a fairly indolent course and prolonged survival have been described in the medical literature. We here report on a p...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008
Lorelei A Mucci Yudi Pawitan Francesca Demichelis Katja Fall Jennifer R Stark Hans-Olov Adami Swen-Olof Andersson Ove Andrén Anna S Eisenstein Lars Holmberg Wei Huang Philip W Kantoff Sven Perner Meir J Stampfer Jan-Erik Johansson Mark A Rubin

Tumor molecular markers hold promise to distinguish potentially lethal from indolent prostate cancer and to guide treatment choices. A previous study identified a nine-gene molecular signature in tumors associated with prostate-specific antigen relapse after prostatectomy. We examined this molecular model in relation to prostate cancer death among 172 men with initially localized disease. We qu...

Journal: :Critical reviews in oncology/hematology 2012
Chris H Bangma Monique J Roobol

The early detection of asymptomatic prostate cancer has led to the increased incidence of tumours that are unlikely to become symptomatic during life, so called indolent cancers. The prediction of low risk and indolent prostate cancer is needed to avoid overtreatment by unnecessary invasive therapies, and select men for active surveillance. Some of the currently available nomograms predicting t...

Journal: :Interactive CardioVascular and Thoracic Surgery 2011

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید